- Home
- LAUR vs JANX Comparison
LAUR vs JANX Comparison
Compare LAUR & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAUR
- JANX
- Stock Information
- Founded
- LAUR 1989
- JANX 2017
- Country
- LAUR United States
- JANX United States
- Employees
- LAUR N/A
- JANX N/A
- Industry
- LAUR Other Consumer Services
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- LAUR Real Estate
- JANX Health Care
- Exchange
- LAUR Nasdaq
- JANX Nasdaq
- Market Cap
- LAUR 2.8B
- JANX 2.9B
- IPO Year
- LAUR 2017
- JANX 2021
- Fundamental
- Price
- LAUR $18.51
- JANX $48.52
- Analyst Decision
- LAUR Buy
- JANX Strong Buy
- Analyst Count
- LAUR 2
- JANX 10
- Target Price
- LAUR $18.50
- JANX $65.10
- AVG Volume (30 Days)
- LAUR 720.6K
- JANX 675.5K
- Earning Date
- LAUR 10-31-2024
- JANX 11-06-2024
- Dividend Yield
- LAUR N/A
- JANX N/A
- EPS Growth
- LAUR 137.96
- JANX N/A
- EPS
- LAUR 1.57
- JANX N/A
- Revenue
- LAUR $1,552,681,000.00
- JANX $13,049,000.00
- Revenue This Year
- LAUR $6.85
- JANX $66.30
- Revenue Next Year
- LAUR $3.53
- JANX N/A
- P/E Ratio
- LAUR $11.52
- JANX N/A
- Revenue Growth
- LAUR 9.25
- JANX 54.12
- 52 Week Low
- LAUR $12.45
- JANX $7.79
- 52 Week High
- LAUR $19.12
- JANX $65.60
- Technical
- Relative Strength Index (RSI)
- LAUR 70.55
- JANX 39.32
- Support Level
- LAUR $18.19
- JANX $50.51
- Resistance Level
- LAUR $18.95
- JANX $57.48
- Average True Range (ATR)
- LAUR 0.57
- JANX 2.86
- MACD
- LAUR 0.14
- JANX -0.81
- Stochastic Oscillator
- LAUR 84.52
- JANX 0.66
About LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.